Andrew Galler
Stock Analyst at Morgan Stanley
(0.49)
# 3,938
Out of 4,836 analysts
29
Total ratings
27.78%
Success rate
-16.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $31.00 | +12.90% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $6.42 | +133.64% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $4.98 | +261.45% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $15.75 | +135.00% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $34.03 | +64.58% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $4.64 | +287.93% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $46.96 | +14.99% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $53.30 | -6.18% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $2.34 | +1,780.34% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $26.39 | +1,051.95% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $31.00
Upside: +12.90%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $6.42
Upside: +133.64%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $4.98
Upside: +261.45%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $15.75
Upside: +135.00%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $34.03
Upside: +64.58%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $4.64
Upside: +287.93%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $46.96
Upside: +14.99%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $53.30
Upside: -6.18%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $2.34
Upside: +1,780.34%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $26.39
Upside: +1,051.95%